Last updated 4th June 2021
We commit to ensuring the quality, safety and reliable supply of our products. If the supply of our medicines or vaccines is disrupted in Australia we will publish details here.
At this unprecedented time, we are actively managing our global supply chains to minimise potential disruption, and we are monitoring the situation closely. We will put the needs of patients first at all times.
At present, with the exception of specific supply disruptions as outlined below, we have adequate stock in place in Australia.
Duac Once Daily Gel clindamycin (as phosphate) 1% and benzoyl peroxide 5% topical gel tube
Due to ongoing supply issues Duac is out of stock until the end of August 2021. Please consult your healthcare professional should you require an alternative.
Kozenis (Tafenoquine) a medicine used to treat infection with Plasmodium vivax malaria, will be unavailable from late April, 2021 until November, 2021 when it is resupplied. Alternate medicines continue to be available, and we do not anticipate there to be a major impact to patients.
GSK will be experiencing a shortage of Varilrix (live varicella vaccine) in the private market from late June 2021 until mid-September 2021. We are currently working on ways to expedite shipments to Australia, and in the meantime, we understand that an alternate varicella vaccine remains available in the private market. We do not anticipate significant impacts for patients. For further questions, please contact your healthcare provider.
Please visit the TGA website for ongoing updates to supply.
For more information on GSK's medicines or vaccines, please contact GSK medical information on 1800 033 109.